Skip to main content

AHFS May 2025 Update

This update contains 5 new monographs and 41 revised monographs.

New monographs: Aztreonam and Avibactam Sodium; Chikungunya Vaccine (Recombinant); Meloxicam and Rizatriptan Benzoate; Mirdametinib; Vimseltinib Dihydrate.

Revised monographs: Alirocumab; Anakinra; Apremilast; Asenapine; Asparaginase (Erwinia chrysanthemi) recombinant; Avacopan ; Bexagliflozin; Canagliflozin; Cisatracurium; Clotrimazole; Empagliflozin; Ertugliflozin L-pyroglutamic Acid; Foscarbidopa and Foslevodopa; Glimepiride; Lebrikizumab-lbkz; Lenacapavir; Levacetylleucine; Marstacimab-hncq; Mosunetuzumab-axgb; Nateglinide; Norepinephrine; Pasireotide; Pegunigalsidase alfa-iwxj; Pemivibart; Pioglitazone; Pitolisant; Pneumococcal Vaccine; Repaglinide; Rilpivirine; Rocuronium; Semaglutide; Sertraline; Sotagliflozin; Tislelizumab-jsgr; Tofacitinib; Ublituximab-xiiy; Vandetanib; Vecuronium; Vemurafenib; Vigabatrin; Viltolarsen.